BridgeMD
New treatment option for Knee Osteoarthristis
Official title Close Chain and Open Chain Exercises With Blood Flow Restriction in Knee Osteoarthritis
ClinicalTrials.gov ID: NCT07426549
What this study is testing
- What it's testing
- The aim of this research is to find and compare the effect of close chain and open chain exercises with blood flow restriction in knee osteoarthritis on pain, range of motion, strength and functional performance in patients with knee osteoarthritis. Randomized controlled trials done at Railway General Hospital and Medistic Medical and Dental Center, Rawalpindi.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 75
You may be able to join if
- Radiologic confirmation of KOA demonstrating Kellgren-Lawrence grade 1 or 2.
- Exhibited symptoms of unilateral KOA.
- Not taking any medications for KOA or receiving other treatments (including physiotherapy).
- Willing to participate without any neurological symptoms were the main objects of study.
You likely can't join if
- A history of knee surgery or scheduled surgery.
- Kellgren-Lawrence grade 3 or 4.
- Systolic blood pressure over 160 mm Hg or under 100 mm Hg.
- Use of nonsteroidal anti-inflammatory drugs in the past 3 months.
- Any known vascular disease or any diagnosed blood pathology.
- Concomitant symptomatic hip or ankle pathology that could influence knee pain or function.
The study team makes the final eligibility decision.
Where it's taking place
- Rawalpindi, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 45 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rawalpindi, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.